Three cases (11.5%) showed expressions of the BCR/ABL transcript above 10% (-1 log) at the time of the inclusion, one fell out of follow-up, another exhibited a cytogenetic relapse at 6 months and maintained it until 12 months, and the last held the complete cytogenetic response with decrease of tumor load (Table 4). Here, BCR is linked to neoplasm.